Parkinson's Disease Clinical Trial
Official title:
Asleep Versus Awake Deep Brain Stimulation Surgery
The goal of this study is to compare the surgical outcome of deep brain stimulation (DBS) surgery in patients who are deeply sedated, "asleep," or not sedated, "awake," during surgical implantation of the DBS electrode. The investigators hypothesize that the clinical outcome, neurophysiological findings, and surgical accuracy will be equivalent. There are 3 specific aims: 1) compare the activity of the neurons in the patients' brain in the asleep and awake groups using microelectrode recording, to see how this affects clinical outcome capability of microelectrode recordings and macrostimulation to identify the subthalamic nucleus in asleep patients. 2) Determine if intraoperative CT scans of the DBS electrode is sufficient for accurate DBS electrode placement. 3) Compare the clinical outcome on their Parkinson's disease between awake and asleep DBS patients.
All patients will undergo DBS surgery using regular surgical techniques. In this surgery a
halo is attached to the skull. A CT scan is obtained. MRI - based targeting is conducted to
identify to target location to implant the electrode deep in the brain. The patients have a
burr hole placed just behind their hair line in the frontal lobe. Then a guide tube is
inserted in the brain. Neurophysiological identification and confirmation of the target is
conducted with multiple techniques including microelectrode recording to listen to single
neurons in the brain, and macrostimulation to test clinical effect. The electrode is
implanted and its clinical effect is tested. The halo is removed and the patient is taken to
the recovery room. Patients will be randomized to undergo the surgery awake or asleep. Our
current standard surgical technique is awake with intravenous anesthesia used briefly during
drilling of a burr hole in the skull.
But in selected cases patients have remained sedated throughout the entire surgery. Patients
in the asleep group will have intravenous anesthesia maintained throughout the entire case.
Standard intraoperative neurophysiological and imaging techniques will be used. In awake
patients these techniques are used to identify and confirm that the DBS electrode is
implanted in accurate position. These techniques include microelectrode recording where
individual neurons are monitored as the electrode is inserted through the brain tissue.
Early research reports suggest that sedation may affect the neuronal activity. But our
preliminary data indicates that is still reliable under intravenous anesthesia.
Macrostimulation using the implanted DBS electrode can suppress tremor, stiffness, and
slowness of Parkinson's disease, and assists in confirmation of electrode position. It also
causes side effects including tingling, and facial contractions. These methods will also be
studied in the asleep patients. The O-arm is an intraoperative CT scanner that visualizes
the DBS electrode. O-arm images will be obtained in the standard fashion in both groups. The
accuracy of intraoperative imaging will be compared to standard postoperative MRI. The
clinical outcome from these two techniques will be compared. The clinical outcome will be
measured with standard Parkinson's disease research tools including video taped and
independently rated motor exam, as well as the Unified Parkinson's Disease Rating Scale
(UPDRS). Gait analysis will be collected using the APDM system. These will be tested before
and at 3 months after surgery by the neurologist.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Completed |
NCT02874274 -
Vaccination Uptake (VAX) in PD
|
N/A | |
Terminated |
NCT02924194 -
Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease
|
N/A |